Abstract
A series of novel 2-[4-aryl-5-{(quinolin-8-yloxy)methyl}-4H-1,2,4-triazol-3-ylthio]-1-arylethanones (6a-6j) and 8-{(5-aryl-1,3,4-oxadiazol-2-yl)methoxy}quinolines (7a-7d) were synthesized from the corresponding 4-arnyl-1-(2- quinolin-8-yloxy)acetyl) thiosemicarbazides (4a-4d) and hydrazides (3) respectively. The prepared compounds were screened for their anti-inflammatory, analgesic, ulcerogenic and antimicrobial activities. The anti-inflammatory activities were determined by carrageenan induced rat paw edema method. Compounds 6c, 6d, 6f 6j, 7b and 7e significantly inhibited the rat paw edema depending upon the dose employed. These compounds exhibited insignificant ulceration compared to the standard drug Indomethacin. The compounds were also evaluated for their in vitro antimicrobial activity. Some compounds have shown moderate to good activity whereas compound 7b has shown significant zone of inhibition compared to the standard drug Ampicillin against Gram negative microorganisms.
Keywords: Anti-inflammatory activity,, analgesic, ulcerogenic, animicrobial, 1,3,4-Oxadiazole derivatives, S-substituted phenacyl 1,2,4-, triazole derivatives, thiosemicarbazides, anti-inflammatory, microorganisms
Medicinal Chemistry
Title: Synthesis of Novel 8-Hydroxy Quinolin Based 1,3,4-oxadiazoles and S-substituted 1,2,4-triazole Derivatives and Evaluation of their Anti-inflammatory, Analgesic, Ulcerogenic and Anti-Microbial Activities
Volume: 7 Issue: 6
Author(s): Mohammad Mahboob Alam, Mohammad Shaharyar, Hinna Hamid, Syed Nazreen, Saqlain Haider and Mohammad Sarwar Alam
Affiliation:
Keywords: Anti-inflammatory activity,, analgesic, ulcerogenic, animicrobial, 1,3,4-Oxadiazole derivatives, S-substituted phenacyl 1,2,4-, triazole derivatives, thiosemicarbazides, anti-inflammatory, microorganisms
Abstract: A series of novel 2-[4-aryl-5-{(quinolin-8-yloxy)methyl}-4H-1,2,4-triazol-3-ylthio]-1-arylethanones (6a-6j) and 8-{(5-aryl-1,3,4-oxadiazol-2-yl)methoxy}quinolines (7a-7d) were synthesized from the corresponding 4-arnyl-1-(2- quinolin-8-yloxy)acetyl) thiosemicarbazides (4a-4d) and hydrazides (3) respectively. The prepared compounds were screened for their anti-inflammatory, analgesic, ulcerogenic and antimicrobial activities. The anti-inflammatory activities were determined by carrageenan induced rat paw edema method. Compounds 6c, 6d, 6f 6j, 7b and 7e significantly inhibited the rat paw edema depending upon the dose employed. These compounds exhibited insignificant ulceration compared to the standard drug Indomethacin. The compounds were also evaluated for their in vitro antimicrobial activity. Some compounds have shown moderate to good activity whereas compound 7b has shown significant zone of inhibition compared to the standard drug Ampicillin against Gram negative microorganisms.
Export Options
About this article
Cite this article as:
Mahboob Alam Mohammad, Shaharyar Mohammad, Hamid Hinna, Nazreen Syed, Haider Saqlain and Sarwar Alam Mohammad, Synthesis of Novel 8-Hydroxy Quinolin Based 1,3,4-oxadiazoles and S-substituted 1,2,4-triazole Derivatives and Evaluation of their Anti-inflammatory, Analgesic, Ulcerogenic and Anti-Microbial Activities, Medicinal Chemistry 2011; 7 (6) . https://dx.doi.org/10.2174/157340611797928334
DOI https://dx.doi.org/10.2174/157340611797928334 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Organosulfur Compounds in Cancer Chemoprevention
Mini-Reviews in Medicinal Chemistry Edible Transgenic Plant Vaccines for Different Diseases
Current Pharmaceutical Biotechnology Interaction of Probenecid with the Breast Cancer Resistance Protein Transporter (BCRP/ABCG2)
Letters in Drug Design & Discovery Anticancer Activity of New Haloalkyl Camptothecin Esters against Human Cancer Cell Lines and Human Tumor Xenografts Grown in Nude Mice
Anti-Cancer Agents in Medicinal Chemistry The Fabrication and Application of Bio-Functional Microspheres
Current Organic Chemistry The Genetic Landscapes of Inflammation-Driven Gastrointestinal Tract Cancers
Current Pharmaceutical Design PRL-3, An Emerging Marker of Carcinogenesis, Is Strongly Associated with Poor Prognosis
Anti-Cancer Agents in Medicinal Chemistry Advanced Protein Drugs and Formulations
Current Protein & Peptide Science A Systems Biology Road Map for the Discovery of Drugs Targeting Cancer Cell Metabolism
Current Pharmaceutical Design Th1-mediated Pathology in Mouse Models of Human Disease is Ameliorated by Concurrent Th2 Responses to Parasite Antigens
Current Topics in Medicinal Chemistry Is the Cytoskeleton an Intracellular Receptor for Adrenomedullin and PAMP?
Current Protein & Peptide Science Cyclodextrin Based Nanosponges: Impending Carters in Drug Delivery and Nanotherapeutics
Current Drug Therapy Pharmacokinetics of Recombinant Human Endostatin in Rats
Current Drug Metabolism Editorial [Hot Topic: An Up-Date of Olive Oil and Bioactive Constituents in Health: Molecular Mechanisms and Clinical Implications (Executive Guest Editor: Catalina Alarcon de la Lastra Romero)]
Current Pharmaceutical Design EGFR(s) in Aging and Carcinogenesis of the Gastrointestinal Tract
Current Protein & Peptide Science Potential Applications of Induced Pluripotent Stem Cells (iPSCs) in the Modeling of Gastrointestinal Disorders
Current Stem Cell Research & Therapy Cisplatin Properties in a Nanobiotechnological Approach to Cancer: A Mini-Review
Current Cancer Drug Targets Cyclooxygenase-2 Inhibitors: A Painful Lesson
Cardiovascular & Hematological Disorders-Drug Targets Beneficial and Detrimental Effects of Antioxidants Use in Sports: How is it Balanced?
Current Nutraceuticals Hexosomes: A Novel Drug Delivery System
Current Drug Delivery